Table 6. Cumulative content of salidroside and p-tyrosol in faecal samples following i.v. and i.g. administration of salidroside (i.v. 50 mg·kg⁻¹, i.g. 100 mg·kg⁻¹) (n = 6).

Time (h)	i.v. administration (µg)		i.g. administration (µg)
	Salidroside	p-tyrosol	Salidroside	i.g.
0–12	2.73±0.51	13.79±0.71	Nd	0.01±0.00
12–24	13.90±1.60	10.73±1.75	Nd	0.03±0.01
24–48	19.34±1.51	50.60±2.73	Nd	0.04±0.02
48–72	1.06±0.07	9.71±0.87	Nd	0.03±0.00
0–72	37.04±1.06	85.03±2.21	Nd	0.13±0.03
Excretion (% of dose)	0.30±0.01	1.48±0.04	Nd	0.00±0.00

Nd: not detectable.